Trials / Completed
CompletedNCT00762164
Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
Comparative Efficacy of a Vytorin 10/80 Tablet Split Into 4 (Estimated Dose Ezetimibe 2.5 + Simvastatin 20) Versus Simvastatin 20 Milligrams on LDL Cholesterol
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Bronx VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the efficacy of a Vytorin 10/80 tablet, an approved agent for the treatment of elevated LDL cholesterol which combines the cholesterol absorption inhibitor Ezetimibe 10 mg and simvastatin 80 mg, when split into 4 using a tablet splitter, versus a whole simvastatin 20 milligram tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vytorin | Vytorin 10/80 split into 4 |
| DRUG | Simvastatin | Simvastatin 20 milligrams |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2008-09-30
- Last updated
- 2013-07-03
- Results posted
- 2013-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00762164. Inclusion in this directory is not an endorsement.